Ranbaxy unit launches generic atorvastatin in South Africa
Moneylife Digital Team 08 June 2010

Ranbaxy Laboratories Ltd said its subsidiary Ranbaxy S. A. has launched generic atorvastatin, 'Lipogen', a cholesterol reducing medication in the South African market.

Ranbaxy is the first generic pharmaceutical company to launch a generic atorvastatin in that country.

On Tuesday, Ranbaxy shares ended 1.6% down at Rs415 on the Bombay Stock Exchange, while the benchmark Sensex closed 1% down at 16,617 points.

Comments
Free Helpline
Legal Credit
Feedback